Coxiella burnetii: Host and bacterial responses to infection

Vaccine

Volumn 25, Issue 42, 2007, Pages 7288-7295

  Waag, David M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Coxiella; Immune response; Immunomodulation; Infection; Q fever; Vaccine

Indexed keywords

Q FEVER VACCINE;

ANTIBODY RESPONSE; BACTERIAL KINETICS; BACTERIAL STRAIN; BIOLOGICAL WARFARE; BIOSAFETY; CELL CULTURE; CELLULAR IMMUNITY; CLINICAL FEATURE; CLINICAL TRIAL; COXIELLA BURNETII; DENDRITIC CELL; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFECTION RISK; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; Q FEVER; REVIEW; UNSPECIFIED SIDE EFFECT; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; BACTERIAL VACCINES; BIOTERRORISM; COXIELLA BURNETII; HUMANS; Q FEVER;

EID: 34748829871     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.002     Document Type: Review

References (99)

1. Derrick E.H. Q fever, a new fever entity: clinical features, diagnosis and laboratory investigation. Med J Aust 2 (1937) 281
2. Davis G., and Cox H. A filter-passing infectious agent isolated from ticks. I. Isolation from Dermacentor andersoni, reactions in animals, and filtration experiments. Public Health Rep 53 (1938) 2259-2267
3. Cox H. A filter-passing infectious agent isolated from ticks. III. Description of organism and cultivation experiments. Public Health Rep 53 (1938) 2270-2276
4. Dyer R.E. A filter-passing infectious agent isolated from ticks. IV. Human infection. Public Health Rep 53 (1938) 2277-2283
5. Cox H.R. Studies of a filter-passing infectious agent isolated from ticks. V. Further attempts to cultivate in cell-free media. Suggested classification. Public Health Rep 54 (1939) 1822-1827
6. Derrick E.H. Rickettsia burnetii: the cause of "Q" fever. Med J Aust 1 (1939) 14
7. Philip C.B. Comments on the name of the Q fever organism. Public Health Rep 63 (1948) 58
8. Luoto L., and Huebner R.J. Q fever studies in Southern California. IX. Isolation of Q fever organisms from paturient placentas of naturally infected dairy cows. Public Health Rep 65 (1950) 541
9. Welsh H.H., Lennette E.H., Abinanti F.R., and Winn J.F. Q fever in California. IV. Occurrence of Coxiella burnetii in the placenta of naturally infected sheep. Public Health Rep 66 45 (1951) 1473-1477
10. Waag D., Williams J., Peacock M., and Raoult D. Methods for isolation, amplification, and purification of Coxiella burnetii. In: Williams J., and Thompson H.A. (Eds). Q fever: the biology of Coxiella burnetii (1991), CRC Press, Boca Raton 73-115
11. McCaul T.F., and Williams J.C. Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol 147 3 (1981) 1063-1076
12. Samuel J.E. Developmental cycle of Coxiella burnetii. In: Brun Y.V., and Shimkets L.J. (Eds). Procaryotic development (2000), ASM Press, Washington, DC 427-440
13. McCaul T.F., Banerjee-Bhatnagar N., and Williams J.C. Antigenic differences between Coxiella burnetii cells revealed by postembedding immunoelectron microscopy and immunoblotting. Infect Immun 59 9 (1991) 3243-3253
14. Stoker M.G., and Fiset P. Phase variation of the Nine Mile and other strains of Rickettsia burneti. Can J Microbiol 2 3 (1956) 310-321
15. Moos A., and Hackstadt T. Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect Immun 55 5 (1987) 1144-1150
16. Hoover T.A., Culp D.W., Vodkin M.H., Williams J.C., and Thompson H.A. Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain. Infect Immun 70 12 (2002) 6726-6733
17. Vodkin M.H., and Williams J.C. Overlapping deletion in two spontaneous phase variants of Coxiella burnetii. J Gen Microbiol 132 Pt 9 (1986) 2587-2594
18. Mege J.L., Maurin M., Capo C., and Raoult D. Coxiella burnetii: the 'query' fever bacterium. A model of immune subversion by a strictly intracellular microorganism. FEMS Microbiol Rev 19 4 (1997) 209-217
19. Capo C., Lindberg F.P., Meconi S., Zaffran Y., Tardei G., Brown E.J., et al. Subversion of monocyte functions by Coxiella burnetii: impairment of the cross-talk between alphavbeta3 integrin and CR3. J Immunol 163 11 (1999) 6078-6085
20. Honstettre A., Ghigo E., Moynault A., Capo C., Toman R., Akira S., et al. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4. J Immunol 172 6 (2004) 3695-3703
21. Akporiaye E.T., and Baca O.G. Superoxide anion production and superoxide dismutase and catalase activities in Coxiella burnetii. J Bacteriol 154 1 (1983) 520-523
22. Mo Y.Y., Cianciotto N.P., and Mallavia L.P. Molecular cloning of a Coxiella burnetii gene encoding a macrophage infectivity potentiator (Mip) analogue. Microbiology 141 Pt 11 (1995) 2861-2871
23. Zamboni D.S., McGrath S., Rabinovitch M., and Roy C.R. Coxiella burnetii express type IV secretion system proteins that function similarly to components of the Legionella pneumophila Dot/Icm system. Mol Microbiol 49 4 (2003) 965-976
24. Heinzen R.A., Frazier M.E., and Mallavia L.P. Coxiella burnetii superoxide dismutase gene: cloning, sequencing, and expression in Escherichia coli. Infect Immun 60 9 (1992) 3814-3823
25. DeLay P.D., Lennette E.H., and Deome K.B. Q fever in California. II. Recovery of Coxiella burnetii from naturally infected airborne dust. J Immunol 65 (1959) 211-220
26. Tigertt W.D., Benenson A.S., and Gouchenour W.S. Airborne Q fever. Bacteriol Rev 25 (1961) 285-293
27. Behymer D.E., Biberstein E.L., Riemann H.P., Franti C.E., Sawyer M., Ruppanner R., et al. Q fever (Coxiella burnetii) investigations in dairy cattle: challenge of immunity after vaccination. Am J Vet Res 37 6 (1976) 631-634
28. Rose M., Wemheuer W., and Schmidt F.W. Follow-up studies of the detection of IgG1 antibodies to Coxiella burnetii in blood and milk from cattle in relation to the reproductive cycle and milk production. Dtsch Tierarztl Wochenschr 101 12 (1994) 484-486
29. Langley J.M., Marrie T.J., Leblanc J.C., Almudevar A., Resch L., and Raoult D. Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes. Am J Obstet Gynecol 189 1 (2003) 228-232
30. Raoult D., Fenollar F., and Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med 162 6 (2002) 701-704
31. Marrie T. Epidemiology of Q fever. In: Marrie T. (Ed). Q fever: the disease (1990), CRC Press, Boca Raton 49-70
32. Russell-Lodrigue K.E., Zhang G.Q., McMurray D.N., and Samuel J.E. Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever. Infect Immun 74 11 (2006) 6085-6091
33. Hackstadt T., and Williams J.C. Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc Natl Acad Sci U SA 78 5 (1981) 3240-3244
34. Khavkin T.N. Pathologo-anatomic and experimental study of the morphology of Q-fever. Arkh Patol 39 2 (1977) 75-84
35. Maurin M., and Raoult D. Q fever. Clin Microbiol Rev 12 4 (1999) 518-553
36. Sawyer L.A., Fishbein D.B., and McDade J.E. Q fever: current concepts. Rev Infect Dis 9 5 (1987) 935-946
37. Tigertt W.D., and Benenson A.S. Studies on Q fever in man. Trans Assoc Am Phys 69 (1956) 98-104
38. Derrick E.H. The course of infection with Coxiella burneti. Med J Aust 1 21 (1973) 1051-1057
39. Marrie T. Acute Q Fever. In: Marrie T. (Ed). Q fever, the disease (1990), CRC Press, Boca Raton 125-160
40. Fournier P.E., Marrie T.J., and Raoult D. Diagnosis of Q fever. J Clin Microbiol 36 7 (1998) 1823-1834
41. Ferrante M.A., and Dolan M.J. Q fever meningoencephalitis in a soldier returning from the Persian Gulf War. Clin Infect Dis 16 4 (1993) 489-496
42. Tissot-Dupont H., Vaillant V., Rey S., and Raoult D. Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis 44 2 (2007) 232-237
43. Raoult D., Raza A., and Marrie T. Q fever endocarditis and other forms of chronic Q fever. In: Marrie T. (Ed). Q fever: the disease (1990), CRC Press, Boca Raton 179-199
44. Heard S.R., Ronalds C.J., and Heath R.B. Coxiella burnetii infection in immunocompromised patients. J Infect 11 1 (1985) 15-18
45. Raoult D., Levy P.Y., Dupont H.T., Chicheportiche C., Tamalet C., Gastaut J.A., et al. Q fever and HIV infection. AIDS 7 1 (1993) 81-86
46. Tobin M.J., Cahill N., Gearty G., Maurer B., Blake S., Daly K., et al. Q fever endocarditis. Am J Med 72 3 (1982) 396-400
47. Brouqui P., Dupont H.T., Drancourt M., Berland Y., Etienne J., Leport C., et al. Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med 153 5 (1993) 642-648
48. Fenollar F., Fournier P.E., Carrieri M.P., Habib G., Messana T., and Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 33 3 (2001) 312-316
49. Marmion B.P., Storm P.A., Ayres J.G., Semendric L., Mathews L., Winslow W., et al. Long-term persistence of Coxiella burnetii after acute primary Q fever. QJM 98 1 (2005) 7-20
50. Penttila I.A., Harris R.J., Storm P., Haynes D., Worswick D.A., and Marmion B.P. Cytokine dysregulation in the post-Q-fever fatigue syndrome. QJM 91 8 (1998) 549-560
51. Helbig K., Harris R., Ayres J., Dunckley H., Lloyd A., Robson J., et al. Immune response genes in the post-Q-fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever. QJM 98 8 (2005) 565-574
52. Zhang G., To H., Russell K.E., Hendrix L.R., Yamaguchi T., Fukushi H., et al. Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease. Infect Immun 73 3 (2005) 1561-1567
53. Glazunova O., Roux V., Freylikman O., Sekeyova Z., Fournous G., Tyczka J., et al. Coxiella burnetii genotyping. Emerg Infect Dis 11 8 (2005) 1211-1217
54. Brennan R.E., Russell K., Zhang G., and Samuel J.E. Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect Immun 72 11 (2004) 6666-6675
55. Kishimoto R.A., Rozmiarek H., and Larson E.W. Experimental Q fever infection in congenitally athymic nude mice. Infect Immun 22 1 (1978) 69-71
56. Turco J., Thompson H.A., and Winkler H.H. Interferon-gamma inhibits growth of Coxiella burnetii in mouse fibroblasts. Infect Immun 45 3 (1984) 781-783
57. Humphres R.C., and Hinrichs D.J. Role of antibody in Coxiella burnetii infection. Infect Immun 31 2 (1981) 641-645
58. Kishimoto R.A., and Walker J.S. Interaction between Coxiella burnetii and guinea pig peritoneal macrophages. Infect Immun 14 2 (1976) 416-421
59. Honstettre A., Meghari S., Nunes J.A., Lepidi H., Raoult D., Olive D., et al. Role for the CD28 molecule in the control of Coxiella burnetii infection. Infect Immun 74 3 (2006) 1800-1808
60. Dupuis G., Peter O., Luthy R., Nicolet J., Peacock M., and Burgdorfer W. Serological diagnosis of Q fever endocarditis. Eur Heart J 7 12 (1986) 1062-1066
61. Peter O., Dupuis G., Burgdorfer W., and Peacock M. Evaluation of the complement fixation and indirect immunofluorescence tests in the early diagnosis of primary Q fever. Eur J Clin Microbiol 4 4 (1985) 394-396
62. Peacock M.G., Philip R.N., Williams J.C., and Faulkner R.S. Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect Immun 41 3 (1983) 1089-1098
63. Waag D., Chulay J., Marrie T., England M., and Williams J. Validation of an enzyme immunoassay for serodiagnosis of acute Q fever. Eur J Clin Microbiol Infect Dis 14 5 (1995) 421-427
64. Gikas A., Kofteridis D.P., Manios A., Pediaditis J., and Tselentis Y. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother 45 12 (2001) 3644-3646
65. Raoult D., Houpikian P., Tissot Dupont H., Riss J.M., Arditi-Djiane J., and Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med 159 2 (1999) 167-173
66. Shannon J.G., Howe D., and Heinzen R.A. Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule. Proc Natl Acad Sci USA 102 24 (2005) 8722-8727
67. Shannon J.G., Howe D., and Heinzen R.A. Lack of dendritic cell maturation following infection by Coxiella burnetii synthesizing different lipopolysaccharide chemotypes. Ann N Y Acad Sci 1063 (2005) 154-160
68. Zamboni D.S., Campos M.A., Torrecilhas A.C., Kiss K., Samuel J.E., Golenbock D.T., et al. Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection. J Biol Chem 279 52 (2004) 54405-54415
69. Meghari S., Honstettre A., Lepidi H., Ryffel B., Raoult D., and Mege J.L. TLR2 is necessary to inflammatory response in Coxiella burnetii infection. Ann N Y Acad Sci 1063 (2005) 161-166
70. Koster F.T., Williams J.C., and Goodwin J.S. Cellular immunity in Q fever: specific lymphocyte unresponsiveness in Q fever endocarditis. J Infect Dis 152 6 (1985) 1283-1289
71. Koster F.T., Williams J.C., and Goodwin J.S. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit. J Immunol 135 2 (1985) 1067-1072
72. Ghigo E., Capo C., Raoult D., and Mege J.L. Interleukin-10 stimulates Coxiella burnetii replication in human monocytes through tumor necrosis factor down-modulation: role in microbicidal defect of Q fever. Infect Immun 69 4 (2001) 2345-2352
73. Capo C., Zaffran Y., Zugun F., Houpikian P., Raoult D., and Mege J.L. Production of interleukin-10 and transforming growth factor beta by peripheral blood mononuclear cells in Q fever endocarditis. Infect Immun 64 10 (1996) 4143-4147
74. Damrow T.A., Williams J.C., and Waag D.M. Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase I Coxiella burnetii. Infect Immun 47 1 (1985) 149-156
75. Waag D.M., and Williams J.C. Immune modulation by Coxiella burnetii: characterization of a phase I immunosuppressive complex differentially expressed among strains. Immunopharmacol Immunotoxicol 10 2 (1988) 231-260
76. Williams J.C., Damrow T.A., Waag D.M., and Amano K. Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice. Infect Immun 51 3 (1986) 851-858
77. Williams J.C. Infectivity, virulence, and pathogenesis of Coxiella burnetii for various hosts. In: Williams J.C., and Thompson H.A. (Eds). Q fever: the biology of Coxiella burnetii (1991), CRC Press, Inc., Boca Raton, FL 21-71
78. Clark I.A. Resistance to Babesia spp. and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii. Infect Immun 24 2 (1979) 319-325
79. Kelly M.T., Granger D.L., Ribi E., Milner K.C., Strain S.M., and Stoenner H.G. Tumor regression with Q fever rickettsiae and a mycobacterial glycolipid. Cancer Immunol Innunother 1 (1976) 187-191
80. Waag D.M., Kende M., Damrow T.A., Wood O.L., and Williams J.C. Injection of inactivated phase I Coxiella burnetii increases non-specific resistance to infection and stimulates lymphokine production in mice. Ann N Y Acad Sci 590 (1990) 203-214
81. Smadel J.E., Snyder M.J., and Robins F.C. Vaccination against Q fever. Am J Hyg 47 (1948) 71-78
82. Ormsbee R.A., Bell E.J., Lackman D.B., and Tallent G. The influence of phase on the protective potency of Q fever vaccine. J Immunol 92 (1964) 404-412
83. Fiset P. Vaccination against Q fever. In: Vaccines against viral and rickettsial diseases in man, PAHO Science Publication Number 147. Wahington, DC: Pan American Health Organization; 1966. p. 528-31.
84. Bell J.F., Lackman D.B., Meis A., and Hadlow W.J. Recurrent reaction of site of Q fever vaccination in a sensitized person. Mil Med 129 (1964) 591-595
85. Benenson AS. Q fever vaccine: efficacy and present status. In: Smadel JE, editor. Symposium on Q fever. Washington, DC: Walter Reed Army Institute of Medical Science, Publ. No. 6, Government Printing Office; 1959.
86. Lackman D., Bell E.J., Bell J.F., and Pickens E. Intradermal sensitivity testing in man with a purified vaccine for Q fever. Am J Public Health 52 (1962) 87-93
87. Ackland J.R., Worswick D.A., and Marmion B.P. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med J Aust 160 11 (1994) 704-708
88. Izzo A.A., Marmion B.P., and Hackstadt T. Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens. Clin Exp Immunol 85 1 (1991) 98-108
89. Genig V.A. A live vaccine 1/M-44 against Q fever for oral use. J Hyg Epidemiol Microbiol Immunol 12 (1968) 265-273
90. Johnson J.W., McLeod C.G., Stookey J.L., Higbee G.A., and Pedersen Jr. C.E. Lesions in guinea pigs infected with Coxiella burnetii strain M-44. J Infect Dis 135 6 (1977) 995-998
91. Williams J.C., and Cantrell J.L. Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice. Infect Immun 35 3 (1982) 1091-1102
92. Fries L.F., Waag D.M., and Williams J.C. Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever. Infect Immun 61 4 (1993) 1251-1258
93. Brooks D.L., Ermel R.W., Franti C.E., Ruppanner R., Behymer D.E., Williams J.C., et al. Q fever vaccination of sheep: challenge of immunity in ewes. Am J Vet Res 47 6 (1986) 1235-1238
94. Waag D.M., England M.J., and Pitt M.L. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol. Vaccine 15 16 (1997) 1779-1783
95. Waag D.M., England M.J., Tammariello R.F., Byrne W.R., Gibbs P., Banfield C.M., et al. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 20 19-20 (2002) 2623-2634
96. Li Q., Niu D., Wen B., Chen M., Qiu L., and Zhang J. Protective immunity against Q fever induced with a recombinant P1 antigen fused with HspB of Coxiella burnetii. Ann N Y Acad Sci 1063 (2005) 130-142
97. Tyczka J., Eberling S., and Baljer G. Immunization experiments with recombinant Coxiella burnetii proteins in a murine infection model. Ann N Y Acad Sci 1063 (2005) 143-148
98. Zhang G.Q., and Samuel J.E. Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I. Ann N Y Acad Sci 990 (2003) 510-520
99. Alibek K., and Biohazard. The chilling true story of the largest covert biological weapons program in the world (1999), Random House, New York